Management Of Native Lung Malignancy In The Lung Transplant Recipient
Jairo A. Espinosa, M.D., Charles Bakhos, MD, Cherie Erkmen, MD, Roman Petrov, M.D..
Temple University Hospital, Philadelphia, PA, USA.
BACKGROUND:
75 year old male with history of previous right lung transplant presenting with left upper lobe squamous cell carcinoma. EBUS and PET displayed no mediastinal lymphadenopathy. V/Q scan displayed minimal perfusion to the native lung. Left robotic assisted lysis of adhesions, decortication, left upper lobectomy, and mediastinal lymphadenectomy were performed. Patient tolerated the procedure well. Final pathology displayed pT2a, n0, m0.
CONCLUSIONS: Lobectomy is a safe and efficient treatment of native lung malignancy in the setting of previous lung transplant with minimally functioning native lung.
Back to 2022 Abstracts